Association between gut microbial diversity and technique failure in peritoneal dialysis patients

References

• Li PK, Chow KM, Van de Luijtgaarden MW, et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2017;13(2):90–103.
   PubMed Web of Science ®Google Scholar
• Li P, Cao X, Liu W, et al. Evolving peritoneal dialysis care in chinese mainland from 2010 to 2020: comparison data from two surveys. Semin Dial. 2022:1–7.
   Web of Science ®Google Scholar
• Chang YT, Hwang JS, Hung SY, et al. Cost-effectiveness of hemodialysis and peritoneal dialysis: a national cohort study with 14 years follow-up and matched for comorbidities and propensity score. Sci Rep. 2016;6:30266.
   PubMed Web of Science ®Google Scholar
• Chuasuwan A, Pooripussarakul S, Thakkinstian A, et al. Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis: a systematic review and meta-analysis. Health Qual Life Outcomes. 2020;18(1):191.
   PubMed Web of Science ®Google Scholar
• Teruel-Briones JL, Fernandez-Lucas M, Rivera-Gorrin M, et al. Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis. Nefrologia. 2013;33(5):640–649.
   PubMed Web of Science ®Google Scholar
• Alexandrou ME, Loutradis C, Balafa O, et al. A comparative study of ambulatory Central hemodynamics and arterial stiffness parameters in peritoneal dialysis and hemodialysis patients. J Hypertens. 2020;38(12):2393–2403.
   PubMed Web of Science ®Google Scholar
• Bello AK, Okpechi IG, Osman MA, et al. Epidemiology of peritoneal dialysis outcomes. Nat Rev Nephrol. 2022;18(12):779–793.
   PubMed Web of Science ®Google Scholar
• Da Luz LG, Ankawi G, Digvijay K, et al. Technique failure in peritoneal dialysis: etiologies and risk assessment. Blood Purif. 2021;50(1):42–49.
   PubMed Web of Science ®Google Scholar
• Kamada N, Chen GY, Inohara N, et al. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol. 2013;14(7):685–690.
   PubMed Web of Science ®Google Scholar
• Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Med. 2016;8(1):51.
   PubMed Web of Science ®Google Scholar
• Wu IW, Lin CY, Chang LC, et al. Gut microbiota as diagnostic tools for mirroring disease progression and circulating nephrotoxin levels in chronic kidney disease: discovery and validation study. Int J Biol Sci. 2020;16(3):420–434.
   PubMed Web of Science ®Google Scholar
• Ren Z, Fan Y, Li A, et al. Alterations of the human gut microbiome in chronic kidney disease. Adv Sci. 2020;7(20):2001936.
   Web of Science ®Google Scholar
• Hu X, Ouyang S, Xie Y, et al. Characterizing the gut microbiota in patients with chronic kidney disease. Postgrad Med. 2020;132(6):495–505.
   PubMed Web of Science ®Google Scholar
• Zhao J, Ning X, Liu B, et al. Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review. Ren Fail. 2021;43(1):102–112.
   PubMed Web of Science ®Google Scholar
• Jiang N, Zhang C, Feng H, et al. Clinical characteristics associated with the properties of gut microbiota in peritoneal dialysis patients. Perit Dial Int. 2021;41(3):298–306.
   PubMed Web of Science ®Google Scholar
• Bao M, Zhang P, Guo S, et al. Altered gut microbiota and gut-derived p-cresyl sulfate serum levels in peritoneal dialysis patients. Front Cell Infect Microbiol. 2022;12:639624.
   PubMed Web of Science ®Google Scholar
• Stadlbauer V, Horvath A, Ribitsch W, et al. Structural and functional differences in gut microbiome composition in patients undergoing haemodialysis or peritoneal dialysis. Sci Rep. 2017;7(1):15601.
   PubMedGoogle Scholar
• Bhargava S, Merckelbach E, Noels H, et al. Homeostasis in the gut microbiota in chronic kidney disease. Toxins. 2022;14(10):648.
   PubMed Web of Science ®Google Scholar
• Peled JU, Gomes ALC, Devlin SM, et al. Microbiota as predictor of mortality in allogeneic Hematopoietic-Cell transplantation. N Engl J Med. 2020;382(9):822–834.
   PubMed Web of Science ®Google Scholar
• Lin TY, Wu PH, Lin YT, et al. Gut dysbiosis and mortality in hemodialysis patients. NPJ Biofilms Microbiomes. 2021;7(1):20.
   PubMed Web of Science ®Google Scholar
• Davies SJ, Phillips L, Naish PF, et al. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol. 2001;12(5):1046–1051.
   PubMed Web of Science ®Google Scholar
• Cao XS, Chen J, Zou JZ, et al. Association of indoxyl sulfate with heart failure among patients on hemodialysis. Clin J Am Soc Nephrol. 2015;10(1):111–119.
   PubMed Web of Science ®Google Scholar
• Szeto CC, Chow KM, Leung CB, et al. Assessment of protein nitrogen appearance in Chinese peritoneal dialysis patients-which method to use? Ren Fail. 2003;25(2):235–246.
   PubMed Web of Science ®Google Scholar
• Wang L, Wang T. Adequacy of peritoneal dialysis: kt/V revisited. Eur Rev Med Pharmacol Sci. 2015;19(7):1272–1275.
   PubMed Web of Science ®Google Scholar
• Klindworth A, Pruesse E, Schweer T, et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2013;41(1):e1.
   PubMed Web of Science ®Google Scholar
• Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013;10(10):996–998.
   PubMed Web of Science ®Google Scholar
• Bolyen E, Rideout JR, Dillon MR, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852–857.
   PubMed Web of Science ®Google Scholar
• Schloss PD, Westcott SL, Ryabin T, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009;75(23):7537–7541.
   PubMed Web of Science ®Google Scholar
• Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335–336.
   PubMed Web of Science ®Google Scholar
• Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60.
   PubMed Web of Science ®Google Scholar
• Lan PG, Clayton PA, Johnson DW, et al. Duration of hemodialysis following peritoneal dialysis cessation in Australia and New Zealand: proposal for a standardized definition of technique failure. Perit Dial Int. 2016;36(6):623–630.
   PubMed Web of Science ®Google Scholar
• Li PK, Chow KM, Cho Y, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022;42(2):110–153.
   PubMed Web of Science ®Google Scholar
• Zhu Y, He C, Li X, et al. Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and mice. J Gastroenterol. 2019;54(4):347–358.
   PubMed Web of Science ®Google Scholar
• Cattaneo A, Cattane N, Galluzzi S, et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging. 2017;49:60–68.
   PubMed Web of Science ®Google Scholar
• Zheng Q, Chen Y, Zhai Y, et al. Gut dysbiosis is associated with the severity of cryptogenic stroke and enhanced systemic inflammatory response. Front Immunol. 2022;13:836820.
   PubMed Web of Science ®Google Scholar
• Mohr AE, Crawford M, Jasbi P, et al. Lipopolysaccharide and the gut microbiota: considering structural variation. FEBS Lett. 2022;596(7):849–875.
   PubMed Web of Science ®Google Scholar
• Li X, He C, Li N, et al. The interplay between the gut microbiota and NLRP3 activation affects the severity of acute pancreatitis in mice. Gut Microbes. 2020;11(6):1774–1789.
   PubMed Web of Science ®Google Scholar
• De la Fuente M, Franchi L, Araya D, et al. Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome. Int J Med Microbiol. 2014;304(3-4):384–392.
   PubMed Web of Science ®Google Scholar
• de Lima SM, Otoni A, Sabino Ade P, et al. Inflammation, neoangiogenesis and fibrosis in peritoneal dialysis. Clin Chim Acta. 2013;421:46–50.
   PubMed Web of Science ®Google Scholar
• Shi J, Yu M, Sheng M. Angiogenesis and inflammation in peritoneal dialysis: the role of adipocytes. Kidney Blood Press Res. 2017;42(2):209–219.
   PubMed Web of Science ®Google Scholar
• Wang AY. Consequences of chronic inflammation in peritoneal dialysis. Semin Nephrol. 2011;31(2):159–171.
   PubMed Web of Science ®Google Scholar
• Lambie M, Chess J, Donovan KL, et al. Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival. J Am Soc Nephrol. 2013;24(12):2071–2080.
   PubMed Web of Science ®Google Scholar
• Vojinovic D, Radjabzadeh D, Kurilshikov A, et al. Relationship between gut microbiota and circulating metabolites in population-based cohorts. Nat Commun. 2019;10(1):5813.
   PubMedGoogle Scholar
• Fu J, Bonder MJ, Cenit MC, et al. The gut microbiome contributes to a substantial proportion of the variation in blood lipids. Circ Res. 2015;117(9):817–824.
   PubMed Web of Science ®Google Scholar
• Yun KE, Kim J, Kim MH, et al. Major lipids, apolipoproteins, and alterations of gut microbiota. J Clin Med. 2020;9(5):1589.
   Web of Science ®Google Scholar
• Lamprea-Montealegre JA, Staplin N, Herrington WG, et al. Apolipoprotein B, Triglyceride-Rich lipoproteins, and risk of cardiovascular events in persons with CKD. Clin J Am Soc Nephrol. 2020;15(1):47–60.
   PubMed Web of Science ®Google Scholar
• Rader DJ, Hovingh GK. HDL and cardiovascular disease. Lancet. 2014;384(9943):618–625.
   PubMed Web of Science ®Google Scholar
• Wong J, Piceno YM, DeSantis TZ, et al. Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am J Nephrol. 2014;39(3):230–237.
   PubMed Web of Science ®Google Scholar
• Mishima E, Fukuda S, Mukawa C, et al. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach. Kidney Int. 2017;92(3):634–645.
   PubMed Web of Science ®Google Scholar
• Gryp T, Huys GRB, Joossens M, et al. Isolation and quantification of uremic toxin Precursor-Generating gut bacteria in chronic kidney disease patients. Int J Mol Sci. 2020;21(6):1986.
   PubMed Web of Science ®Google Scholar
• Zhang L, Xie F, Tang H, et al. Gut microbial metabolite TMAO increases peritoneal inflammation and peritonitis risk in peritoneal dialysis patients. Transl Res. 2022;240:50–63.
   PubMed Web of Science ®Google Scholar
• Rossi M, Campbell KL, Johnson DW, et al. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease. Arch Med Res. 2014;45(4):309–317.
   PubMed Web of Science ®Google Scholar
• Dou L, Sallee M, Cerini C, et al. The cardiovascular effect of the uremic solute indole-3 acetic acid. J Am Soc Nephrol. 2015;26(4):876–887.
   PubMed Web of Science ®Google Scholar
• Sirich TL, Aronov PA, Plummer NS, et al. Numerous protein-bound solutes are cleared by the kidney with high efficiency. Kidney Int. 2013;84(3):585–590.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhou J, Wang L. Role and mechanism of gut microbiota in human disease. Front Cell Infect Microbiol. 2021;11:625913.
   PubMed Web of Science ®Google Scholar
• Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375(24):2369–2379.
   PubMed Web of Science ®Google Scholar